Loading market data...
Sunday, July 5, 2026
Back to HomeKorea StockPremium

Samsung Life (032830.KS) Q1 2026: ₩18T Capital Surge as Profit Jumps 89%

By MinJeKim6 views
Share
Samsung Life (032830.KS) Q1 2026: ₩18T Capital Surge as Profit Jumps 89%

Samsung Life (032830.KS) Q1 2026: ₩18T Capital Surge as Profit Jumps 89%

A bond-revaluation tailwind lifted equity by nearly a third in a single quarter, even as core insurance margins held steady.

Source: Quarterly Report (71st FY, Q1) — Filed 15 May 2026 with DART | Consolidated Financial Statements | Unit: ₩ billions

Samsung Life Insurance reported controlling-shareholder net income of ₩1,203.6 billion for Q1 2026, an 89.5% jump from ₩635.3 billion a year earlier. The more dramatic story, however, was not in the income statement but in equity — consolidated total equity expanded from ₩64.8 trillion to ₩83.3 trillion in just three months, an ₩18.5 trillion increase driven almost entirely by unrealised gains on FVOCI-classified bonds as Korean rates declined. The K-ICS solvency ratio climbed to 209.9%, up roughly 25 percentage points from the FY2024 level of 184.9%. With IFRS 17 and IFRS 9 now in their third year of application, this quarter offers a textbook illustration of how a large life insurer with a long-duration bond book absorbs the accounting effects of a falling-rate environment.

Unlimited Korean-market analysis, $9.99/month

Samsung Life (032830.KS) Q1 2026: ₩18T Capital Surge as Profit Jumps 89%

This article became available on May 16, 2026. Subscribe to read in full, or wait until August 14, 2026 when it becomes free.

Cancel anytime. Full refund within 7 days.

NewsFinanceMarkets

Go deeper than the headline

You just read what happened. Here's how to read what it means.

For news readers

Get news like this every morning

A short morning email summarizing the key KOSPI & KOSDAQ moves — earnings, disclosures, and foreign flows — in your inbox before the open.

$2.99 · monthly

Get the Morning Briefing
This company

Full report on Samsung Life

We read Samsung Life's latest DART filing in full — financials under K-IFRS, governance, and what it means for the stock. PDF in your inbox in 30–40 min.

$12 · one-time

Get the Samsung Life report
Every name you watch

Follow the whole market

Reading several Korean stocks a week? Get on-demand analysis on any KOSPI or KOSDAQ company, whenever you need it.

$9.99 · monthly

Subscribe

Independent journalism based on primary DART filings — not investment advice. No brokerage affiliation.